Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Dr. Hao Zeng: Advancing Uro-Oncology with Cutting-Edge Technologies and Promoting Standardized Care in Grassroots Settings

    Focusing on global progress while highlighting Chinese innovations, the 8th West China Uro-Oncology Tianfu Academic Conference and the 10th Uro-Oncology Annual Meeting of the Sichuan Anti-Cancer Association were successfully held in Chengdu, Sichuan. Organized by the Sichuan Anti-Cancer Association and hosted by its Urological and Male Reproductive Tumors Committee in collaboration with the Department of…

    2024.12.12
  • ASH 2024 | Tianjin Medical University Cancer Institute and Hospital’s lymphoma team Explores Cutting-Edge Research and Clinical Practice in Lymphoma

    The 66th Annual Meeting of the American Society of Hematology (ASH) was held from December 7–10, 2024, in San Diego, USA. This prestigious gathering brought together global experts and scholars to discuss the latest advancements in hematology. At this year’s conference, the Tianjin Medical University Cancer Institute and Hospital’s lymphoma team presented 6 significant research…

    2024.12.12
  • CCHIO 2024 | Dr. Chunxia Su: Comprehensive Management and Research Design of IITs in Lung Cancer

    Investigator-initiated trials (IITs) refer to clinical research initiated by investigators, conducted in healthcare institutions, and aimed at studying disease diagnosis, treatment, rehabilitation, prognosis, etiology, prevention, and health maintenance. Unlike industry-sponsored trials, IITs are not intended for drug or medical device registration. In recent years, IITs have become an essential part of clinical research, providing critical…

    2024.12.11
  • CCHIO 2024 | Dr. Gang Ding: The Era of “Integration” — Exploring Tumor Rehabilitation and Health Education for a China-Specific Oncology Prevention

    The 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) concluded successfully on November 17. Following the strategic framework of “collaborative integration” in disciplinary development, the conference established dedicated sessions on tumor rehabilitation, health education, cancer prevention, and screening. These sessions offered comprehensive and multidimensional insights into new perspectives, technologies, and concepts for the full-cycle management…

    2024.12.11
  • CCHIO 2024 | Dr. Xinping Cao: Advances in Systemic Therapy for Cervical Cancer

    At the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO), Dr. Xinping Cao from Sun Yat-sen University Cancer Center presented a comprehensive lecture titled “Advances in Systemic Therapy for Cervical Cancer.” Below is a summary of the key highlights.

    2024.12.11
  • Dr. Zhaochong Zeng: Advancing Liver Cancer Care with Targeted Radiotherapy Strategies and Dual MDT Approaches

    China bears a significant burden of liver cancer. To prevent its onset and progression, the country, society, and countless physicians have undertaken extensive measures under the framework of “three-level prevention,” achieving remarkable progress. With the increasing proportion of early diagnosis and treatment of liver cancer in recent years, a key focus for radiotherapy specialists has…

    2024.12.11
  • CCHIO 2024 | Dr. Hong Liu: New Perspectives on Breast Cancer Rehabilitation – The Importance of Psychological Well-being and Multidisciplinary

    Breast cancer not only threatens patients’ lives but also imposes a heavy psychological burden on women. As the number of breast cancer cases continues to rise, its rehabilitation is gaining increasing attention from society. How to effectively promote comprehensive recovery for breast cancer patients has become an important issue in the medical field. During the…

    2024.12.11
  • The 66th American Society of Hematology (ASH) Annual Meeting was grandly held in San Diego, USA, from December 7th to 10th, 2024

    The 66th American Society of Hematology (ASH) Annual Meeting was grandly held in San Diego, USA, from December 7th to 10th, 2024. As one of the most influential platforms for scientific communication in hematology, this global event attracted over 25,000 professionals, including clinicians, researchers, and healthcare leaders from more than 100 countries. The conference covered…

    2024.12.10
«previous next»
Recent Posts
  • Yixian Breast Cancer Conference 2025 | Professor Chang Gong: Stratified Optimization and Precision Escalation/De-Escalation in HER2-Positive Breast Cancer
  • 2025 Yixian Breast Cancer Conference | Professor Kun Wang: Immunotherapy, Chemotherapy, and ADCs Advancing in Parallel to Drive Continued Breakthroughs in Triple-Negative Breast Cancer Outcomes
  • Northern Breast Cancer Forum 2026 | Professor Peng Yuan: Driving Clinical Transformation Through “Three New Forces” and Anticipating Key Updates in the 2026 CSCO Breast Cancer Guidelines
  • Professor Yongsheng Wang: What Has Changed—and What Remains—in Breast Cancer Surgery?
  • CASH 2026 | Science Knows No Borders: A Video Dialogue with International Forum Chair Professor Toshio Suda
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top